Release issued 2nd June 2008
SAN DIEGO, CA, June 2, 2008 – Jaleva Pharmaceuticals LLC announces that MICROBIOTEST has completed Time Kill and MIC studies for Mast-R-Prep, the company’s proprietary, chlorhexidine-based, one-step surgical skin prep product. The MIC and Time Kill results were outstanding. Mast-R-Prep outperformed a major Isopropyl Alcohol / Povidone-Iodine skin prep product already on the market.
Jaleva’s Mast-R-Prep is the only one-step surgical skin prep product in the world that offers a combination of several desirable characteristics. In contrast to other one-step surgical skin prep products, Mast-r-Prep has a long acting kill rate, is fast drying, easy to remove, has increased tackiness that promotes adhesion of drapes, and also utilizes a proprietary technology to trap and kill bacteria.
“We are pleased and are very encouraged to see that the independent findings demonstrated that Mast-R-Prep is a unique and superior product in its antimicrobial properties,” said Mordy Levine, Jaleva’s Chief Executive Officer.
According to Dr. Alex Battaglia, Jaleva President who coordinated the Time Kill and MIC Testing, “Mast-R-Prep is a one-step, Chlorhexidine-based surgical skin prep that outperforms currently available surgical skin prep products. It has several advantages and unique characteristics that surgeons will appreciate.
First, surgical drapes adhere to Mast-R-Prep formulation better than currently available surgical skin prep products.
Second, it has a unique bacteria trapping effect that prevents bacteria from migrating to the surgical wound. Additionally, its tackiness makes Mast-R-Prep more easily detectable. Mast‑R‑Prep dries faster and is more easily removed than currently available surgical skin prep products.
These unique properties and superior qualities will be desirable to surgeons and lead to a sizeable advantage over currently available surgical skin prep products.”
“We believe that Mast-R-Prep will supplant the use of currently available surgical skin prep products given their liabilities, and the desire expressed by surgeons for a product like Mast-R-Prep that meets all their needs.” says Mordy Levine. “Not only does Mast-R-Prep have user-friendly qualities that surgeons will prefer over currently available surgical skin prep products, but we fully expect Mast-R-Prep to outperform and outlast currently available Chlorhexidine-based surgical skin prep products in human efficacy testing scheduled over the next few weeks.”
Formed in 2000, Jaleva LLC is a privately held firm. Jaleva is a leader in the application of its patented resin technology for the improvement of topical medications. Jaleva is engaged in the research & development of delivery vehicles for active ingredients that treat onychomycosis, psoriasis, heel fissures (cracked heels), athlete’s foot and other dermatological conditions.
For inquiries regarding licensing of our products, please contact: Mordy Levine, CEO, 561–573–0094.